A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Pancreatic Cancer|BRAF Mutant Colorectal Cancer|Melanoma|Triple Negative Breast Cancer|Head and Neck Squamous Cell Cancer|Cervical Squamous Cell Cancer|Esophageal Squamous Cell Cancer|Lung Squamous Cell Cancer
Interventions: DRUG: LGK974|BIOLOGICAL: PDR001
Sponsor: Novartis Pharmaceuticals